Lucitanib
In Stock•Starting at $40 for 1 mg•Purity ≥ 98%
| CAS No. | 1058137-23-7 |
|---|---|
| MDL No. | MFCD09607817 |
| MF | C26H25N3O4 |
| MW | 443.50 |
| InChI Key | CUDVHEFYRIWYQD-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 98% | $40 | In Stock | |
| 5 mg | 98% | $95 | In Stock | |
| 10 mg | 98% | $112 | In Stock | |
| 25 mg | 98% | $135 | In Stock | |
| 50 mg | 98% | $227 | In Stock |
Product Information
E-3810 free base is a naphthalenecarboxamide formed by the formal condensation of the carboxy group of (aminocyclopropyl)methoxy-6-methoxyquinolin-4-yl}oxy)-1-naphthoic acid with methylamine. It functions as an antineoplastic agent, a fibroblast growth factor receptor antagonist, and a vascular endothelial growth factor receptor antagonist. It belongs to quinolines, aromatic ethers, cyclopropanes, primary amino compounds, and naphthalenecarboxamides. It is the conjugate base of E-3810(1+).
| CAS No. | 1058137-23-7 |
|---|---|
| Product Name | Lucitanib |
| Heavy Atom Count | 33 | Rotatable Bond Count | 7 |
| Atom Stereo Count | 0 | Bond Stereo Count | 0 |
| HBA | 6 | HBD | 2 |
| TPSA | 95.700 Ų | Charge | 0 |
| Exact Mass | 443.18451 | Complexity | 1364.76 |
| pKa | 7.130 | XLogP | 4.419 |
